By
David Scheinberg, Memorial Sloan Kettering Cancer Center, New York, New York, U.S.A.
Joseph Jurcic, Memorial Sloan Kettering Cancer Center, New York, New York, U.S.A.
Description
New Treatments of Leukemia and Lymphoma describes the most important advances in the therapy of hematopoietic cancers
that have been derived from recent discoveries in cancer cell biology, kinase biochemistry, and immunology.
Detailed descriptions
of the large number of new and effective agents that have recently become available for the treatment of leukemias and lymphomas as well
as an understanding of their mechanisms of action and their integration into current therapy are provided. A number of experimental
drug reagents currently in clinical investigation are also discussed. The therapies include conventional anti-metabolites, monoclonal
antibodies directed to cell surface receptors, antibodies tagged with toxins and radiopharmaceuticals, inhibitors of specific kinases,
stem cell transplants, and engineered T-cells designed to selectively target hematopoietic cancers.
The contents of the book will
allow practitioners and investigators alike to understand what is current and state of the art as well as what to look for in the future.
Included in series
Advances in Pharmacology
Audience:
Oncologists, hematologists, cancer researchers, pharmacologists, pharmaceutical and biotechonology company employees
